DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Meredith KL. et al.
Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.
Ann Surg Oncol 2010;
17: 1159-1167
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.